A new polymorphic determinant distinct from but expressed concomitantly with an HLA-Bw44 specificity

Area of Science:

• Immunology
• Human Leukocyte Antigen (HLA) research
• Serology

Background:

• Monoclonal antibodies are crucial tools for defining cell surface antigens.
• Human Leukocyte Antigen (HLA) molecules play a vital role in immune responses and transplantation.
• Restricted expression of antigenic determinants can provide insights into genetic linkage and molecular structure.

Purpose of the Study:

• To characterize a newly identified antigenic determinant recognized by monoclonal antibody (6.7).
• To investigate the expression pattern and cellular localization of this determinant within a family.
• To determine the relationship between the 6.7 determinant and known HLA specificities.

Main Methods:

• Generation and characterization of a monoclonal antibody (6.7).
• Immunological assays including antibody binding and cell surface capping studies.
• HLA typing of family members and unrelated individuals.
• Immunochemical analysis and antibody blocking experiments using HLA-typing alloantisera.

Main Results:

• Monoclonal antibody 6.7 defined a novel antigenic determinant with restricted expression, found only in the immunizing donor and father.
• The determinant segregated with specific HLA haplotypes within the family.
• Immunochemical and capping studies indicated the determinant resides on a subpopulation of HLA molecules.
• Further studies revealed the 6.7 determinant is located on the same molecules as HLA-Bw44 but is a distinct epitope.

Conclusions:

• The 6.7 antibody identifies a new, genetically restricted epitope on HLA molecules.
• This epitope is associated with HLA-Bw44 but represents a distinct antigenic site.
• The findings contribute to a more refined understanding of HLA polymorphism and epitope mapping.